Oncolytics Biotech EPS Basic from Tax Loss Carryforward (Quarterly) Analysis

Oncolytics Biotech, Inc. (ONCY)

1.12 +0.06 (+5.66%) USD | NASDAQ | Feb 24, 12:07

View EPS Basic from Tax Loss Carryforward (Quarterly) for ONCY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Lexaria Bioscience Corp.	--
Xenon Pharmaceuticals, Inc.	--
ProMIS Neurosciences, Inc.	--